These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3577933)

  • 1. Autoimmune involvement in motor neurone disease.
    Aspin J; Harrison R; Jehanli A; Lunt GG
    Adv Exp Med Biol; 1987; 209():71-3. PubMed ID: 3577933
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological aspects of motor neuron disease.
    Shy ME
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():241-56. PubMed ID: 2183314
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental autoimmune motoneuron disease.
    Engelhardt JI; Appel SH; Killian JM
    Ann Neurol; 1989 Sep; 26(3):368-76. PubMed ID: 2802536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor neuron reactivity of sera from animals with autoimmune models of motor neuron destruction.
    Engelhardt J; Appel SH
    J Neurol Sci; 1990 May; 96(2-3):333-52. PubMed ID: 1695918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy and autoimmune neuromuscular disease.
    Parry GJ; Heiman-Patterson TD
    Semin Neurol; 1988 Sep; 8(3):197-204. PubMed ID: 3057551
    [No Abstract]   [Full Text] [Related]  

  • 6. Histocompatibility antigens associated with motor-neurone disease.
    Behan PO; Durward WF; Dick H
    Lancet; 1976 Oct; 2(7989):803. PubMed ID: 61474
    [No Abstract]   [Full Text] [Related]  

  • 7. Generation of antibodies to gangliosides GM1 and GD1b. Genetic control of fine antigenic specificity.
    Ito H; Yu RK; Latov N
    Ann N Y Acad Sci; 1988; 540():258-60. PubMed ID: 2462804
    [No Abstract]   [Full Text] [Related]  

  • 8. An immune-mediated guinea pig model for lower motor neuron disease.
    Engelhardt J; Joo F
    J Neuroimmunol; 1986 Oct; 12(4):279-90. PubMed ID: 3760155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside.
    Pestronk A; Cornblath DR; Ilyas AA; Baba H; Quarles RH; Griffin JW; Alderson K; Adams RN
    Ann Neurol; 1988 Jul; 24(1):73-8. PubMed ID: 2843079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor neurone disease and hyperthyroid Graves' disease: a chance association?
    McMenamin J; Croxson M
    J Neurol Neurosurg Psychiatry; 1980 Jan; 43(1):46-9. PubMed ID: 6444439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voltage-dependent Ca2+ channels in small cell carcinomas are blocked by autoantibodies from patients with Lambert-Eaton myasthenic syndrome.
    De Aizpurua HJ; Griesmann GE; Lambert EH; Lennon VA
    Ann N Y Acad Sci; 1988; 540():369-71. PubMed ID: 2849894
    [No Abstract]   [Full Text] [Related]  

  • 12. Interference with calcium channels by Lambert Eaton myasthenic syndrome antibody.
    Wray DW; Peers C; Lang B; Lande S; Newsom-Davis J
    Ann N Y Acad Sci; 1987; 505():368-76. PubMed ID: 2446554
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction.
    Appel SH; Engelhardt JI; García J; Stefani E
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):647-51. PubMed ID: 1988960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological factors in neuronal degeneration with particular reference to motor neurone disease.
    Rutter JV; Jehanli A; Harrison R; Lunt GG
    Gerontology; 1987; 33(3-4):187-92. PubMed ID: 3653701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cell dyscrasia and motor neuron disease.
    Latov N
    Adv Neurol; 1982; 36():273-9. PubMed ID: 6817612
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological aspects of amyotrophic lateral sclerosis].
    Selmaj K
    Neurol Neurochir Pol; 1985; 19(4):338-43. PubMed ID: 3005893
    [No Abstract]   [Full Text] [Related]  

  • 17. Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b.
    Nardelli E; Steck AJ; Barkas T; Schluep M; Jerusalem F
    Ann Neurol; 1988 May; 23(5):524-8. PubMed ID: 3389760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosensitization cell membrane diseases: a unifying concept of autoimmune diseases, collagen diseases, neuromyopathies and cancer.
    Makari JG
    J Am Geriatr Soc; 1972 Aug; 20(8):353-68. PubMed ID: 5053454
    [No Abstract]   [Full Text] [Related]  

  • 19. Lambert-Eaton myasthenic syndrome IgG: early morphologic effects and immunolocalization at the motor endplate.
    Engel AG; Fukuoka T; Lang B; Newsom-Davis J; Vincent A; Wray D
    Ann N Y Acad Sci; 1987; 505():333-45. PubMed ID: 3479929
    [No Abstract]   [Full Text] [Related]  

  • 20. Lower motor neuron disease in a patient with autoantibodies against Gal(beta 1-3)GalNAc in gangliosides GM1 and GD1b: improvement following immunotherapy.
    Shy ME; Heiman-Patterson T; Parry GJ; Tahmoush A; Evans VA; Schick PK
    Neurology; 1990 May; 40(5):842-4. PubMed ID: 2330115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.